ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dalingo 330 mg, Retardtabletten - 30
69956005 Gebro Pharma AG
Dalingo 330 mg, Retardtabletten07.10.2025
  07.10.2025
Pregabalin (N03AX16) 
WHO-DDD06.10.2030
01.07.10.30
01.07.10. 
B  
Yes 
IPCI
25.50Yes
    
10 %44.15
7680699560059Synthetika
  
Composition
pregabalinum 330 mg, hypromellosum, hydroxypropylcellulosum, copolymerum methacrylatis butylati basicum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Pregabalin330 mg
BAG: Active AgentDose
Pregabalin330 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Copolymerum Methacrylatis Butylati Basicum  
Crospovidonum  
E 171 color.
E 172 color.
Hydroxypropylcellulosum  
Hypromellosum  
Lacca Drucktinte
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 18.12.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home